News

Current News

ARCS NCC: COVID-19 UPDATE

Posted on Saturday, December 5, 2020

FDA approval of two vaccines for emergency use only eleven months after the genetic sequencing of SARS-CoV-2 is a tribute to global scientific collaboration. The intense research significantly increased knowledge of virology and immunology. Distribution of the vaccines poses huge ethical and logistical challenges. The acceptance of these vaccines as safe and effective is critical to their success in ending this pandemic. Remaining vigilant about preventative measures is equally critical until approximately 70% of the population is immunized. We are all responsible for staying informed by reliable sources. Here are links to information from our partner universities:

Additional information, recommendations, and updates can be found at these sites:

COVID-19 Update